Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular screening of multifocal transitional cell carcinoma of the bladder using p53 mutations as biomarkers.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Oct 1996

Xu X, Stower M J, Reid I N, Garner R C, Burns P A

Abstract excerpt

Thirteen of 28 patients (46%) with grade 2-3 multifocal transitional cell carcinoma (TCC) of the bladder were found to have p53 mutations using DNA sequence analysis. These were subsequently utilized as tumor-specific biomarkers. Analysis of 17 episodes of recurrence from five of the patients revealed that all but one carried the identical mutation to the primary tumor. Thirty urine samples were collected, at...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Urinary Bladder Neoplasms
Share to Biomarkers

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Carcinoma, Transitional Cell

Share to DNA Mutational Analysis

Share to DNA, Neoplasm

Share to Genes, p53

Share to Mutation

Share to Neoplasm Recurrence, Local

Source

Identifiers

PMID: 9816132

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular screening of multifocal transitional cell carcinoma of the bladder using p53 mutations as biomarkers.PMID 9816132Read ↗

Genetic analysis of Tp53 from urine sediment as a tool for diagnosing recurrence and residual of bladder carcinoma.Semantic proximity Read ↗

Prognostic implications of p53 gene mutations in bladder tumors.Semantic proximity Read ↗

Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studiesSemantic proximity Read ↗

Identification of p53 gene mutations in bladder cancers and urine samples.Semantic proximity Read ↗

Genetic alterations in tp53 in recurrent urothelial cancer: a longitudinal study.Semantic proximity Read ↗

Genetic diversity of urinary bladder cancer and the risk of recurrence based on mutation analysis.Semantic proximity Read ↗

Molecular profiling of bladder tumors based on the detection of FGFR3 and TP53 mutations.Semantic proximity Read ↗

P53 mutations as an identification marker for the clonal origin of bladder tumors and its recurrences.Semantic proximity Read ↗

Multifocal transitional cell carcinoma of the bladder and upper urinary tract: molecular screening of clonal origin by characterizing CD44 alternative splicing patterns.Semantic proximity Read ↗

Origin of multifocal carcinomas of the bladder and upper urinary tract: Molecular analysis and clinical implicationsSemantic proximity Read ↗

FGFR3 and Tp53 mutations in T1G3 transitional bladder carcinomas: independent distribution and lack of association with prognosis.Semantic proximity Read ↗

Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.